13 insiders reported 51 Form 4 transactions for Aclaris Therapeutics, Inc. (ACRS) over the past 18 months (most recent 2026-08-04). Recent activity: Kolbeck Roland Wilhelm (Chief Scientific Officer) Buy 36,375 shares, Kolbeck Roland Wilhelm (Chief Scientific Officer) Sell 12,385 shares, GOWEN MAXINE (Director) Buy 11,580 shares, Mehra Anand (Director) Buy 11,580 shares, MILANO VINCENT (Director) Buy 11,580 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-04 | Kolbeck Roland Wilhelm | Chief Scientific Officer | Buy | 36,375 | $0 |
| 2026-08-04 | Kolbeck Roland Wilhelm | Chief Scientific Officer | Sell | 12,385 | $64,402 |
| 2026-06-08 | GOWEN MAXINE | Director | Buy | 11,580 | $0 |
| 2026-06-08 | Mehra Anand | Director | Buy | 11,580 | $0 |
| 2026-06-08 | MILANO VINCENT | Director | Buy | 11,580 | $0 |
| 2026-06-08 | Molineaux Christopher P. | Director | Buy | 11,580 | $0 |
| 2026-06-08 | SCHIFF ANDREW N | Director | Buy | 11,580 | $0 |
| 2026-06-08 | Humphries William D. | Director | Buy | 11,580 | $0 |
| 2026-05-05 | Hall Jesse Wayne | Chief Medical Officer | Buy | 36,375 | $0 |
| 2026-05-05 | Hall Jesse Wayne | Chief Medical Officer | Sell | 9,330 | $41,145 |
| 2026-04-27 | Leonard Braden Michael | 10% Owner | Sell | 300,000 | $1.4M |
| 2026-03-03 | Balthaser Kevin | Chief Financial Officer | Sell | 677 | $1,943 |
| 2026-03-03 | Balthaser Kevin | Chief Financial Officer | Buy | 2,375 | $0 |
| 2026-02-05 | Davis Hugh M. | President and COO | Buy | 18,675 | $0 |
| 2026-02-05 | Loerop James | Chief Business Officer | Buy | 20,875 | $0 |
| 2026-02-05 | Loerop James | Chief Business Officer | Sell | 5,937 | $20,601 |
| 2026-02-05 | Walker Neal | CEO | Buy | 63,475 | $0 |
| 2026-02-05 | Walker Neal | CEO | Sell | 18,611 | $64,580 |
| 2026-02-05 | Balthaser Kevin | Chief Financial Officer | Buy | 22,025 | $0 |
| 2026-02-05 | Balthaser Kevin | Chief Financial Officer | Sell | 6,449 | $22,378 |
| 2026-02-05 | Loerop James | Chief Business Officer | Buy | 11,250 | $0 |
| 2026-02-05 | Loerop James | Chief Business Officer | Buy | 7,500 | $0 |
| 2026-02-05 | Loerop James | Chief Business Officer | Buy | 14,750 | $0 |
| 2026-02-05 | Loerop James | Chief Business Officer | Sell | 10,686 | $37,508 |
| 2026-02-03 | Balthaser Kevin | Chief Financial Officer | Buy | 14,750 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-08-04